{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:21:43Z","timestamp":1787682103117,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012176","name":"Maudsley Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jad.2020.07.102","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T21:16:53Z","timestamp":1595279813000},"page":"991-1000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The magnitude and heterogeneity of antidepressant response in depression: A meta-analysis of over 45,000 patients"],"prefix":"10.1016","volume":"276","author":[{"given":"Xin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"McCutcheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Pillinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Natesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.07.102_bib0001","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1192\/bjp.174.4.297","article-title":"Effectiveness of antidepressants: meta-analysis of dose-effect relationships in randomised clinical trials","volume":"174","author":"Bollini","year":"1999","journal-title":"Br. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2020.07.102_bib0002","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/jamapsychiatry.2017.2663","article-title":"Heterogeneity and homogeneity of regional brain structure in schizophrenia: a meta-analysis","volume":"74","author":"Brugger","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2020.07.102_bib0003","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S2215-0366(16)30024-4","article-title":"Scaling-up treatment of depression and anxiety: a global return on investment analysis","volume":"3","author":"Chisholm","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"10128","key":"10.1016\/j.jad.2020.07.102_bib0004","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.jad.2020.07.102_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamapsychiatry.2016.2586","article-title":"Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough","volume":"74","author":"Conway","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2020.07.102_bib0006","doi-asserted-by":"crossref","first-page":"c4737","DOI":"10.1136\/bmj.c4737","article-title":"Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials","volume":"341","author":"Eyding","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.07.102_bib0008","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jad.2020.07.102_bib0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2020.07.102_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2017.3826","article-title":"Depression is the leading cause of disability around the world","volume":"317","author":"Friedrich","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jad.2020.07.102_bib0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/17460441.2019.1546691","article-title":"Vortioxetine: a novel antidepressant for the treatment of major depressive disorder","volume":"14","author":"Gonda","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jad.2020.07.102_bib0011","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jad.2015.03.021","article-title":"Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials","volume":"180","author":"Hayasaka","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.07.102_bib0012","series-title":"Cochrane Handbook for Systematic Reviews of interventions: Cochrane Book Series","first-page":"187","article-title":"Assessing risk of bias in included studies","author":"Higgins","year":"2008"},{"key":"10.1016\/j.jad.2020.07.102_bib0013","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.07.102_bib0014","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1176\/appi.ajp.2015.15030331","article-title":"Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder","volume":"173","author":"Jakubovski","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"10 Pt 1","key":"10.1016\/j.jad.2020.07.102_bib0035","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.neubiorev.2012.12.007","article-title":"The neurobiology of depression and antidepressant action","volume":"37","author":"Willner","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.jad.2020.07.102_bib0036","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamapsychiatry.2019.1530","article-title":"Evaluation of differences in individual treatment response in schizophrenia spectrum disorders: a meta-analysis","volume":"76","author":"Winkelbeiner","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2020.07.102_bib0016","doi-asserted-by":"crossref","unstructured":"Kirsch, I., Sapirstein, G., 1999. Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medications.","DOI":"10.1037\/\/1522-3736.1.0002a"},{"issue":"1","key":"10.1016\/j.jad.2020.07.102_bib0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004714-200202000-00007","article-title":"Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database","volume":"22","author":"Khan","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.07.102_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jad.2020.07.102_bib0018","article-title":"The efficacy and heterogeneity of antipsychotic response in schizophrenia: a meta-analysis. LID","author":"McCutcheon","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.102_bib0019","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.102_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/2041-210X.12309","article-title":"Meta\u2010analysis of variation: ecological and evolutionary applications and beyond","volume":"6","author":"Nakagawa","year":"2015","journal-title":"Methods Ecol. Evol."},{"key":"10.1016\/j.jad.2020.07.102_bib0021","doi-asserted-by":"crossref","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder. Nature reviews","volume":"2","author":"Otte","year":"2016","journal-title":"Dis. Primers"},{"key":"10.1016\/j.jad.2020.07.102_bib0022","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2020.07.102_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/med.21671","article-title":"New-generation, non-SSRI antidepressants: drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others. LID","author":"Protti","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"1\u20133","key":"10.1016\/j.jad.2020.07.102_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2009.01.029","article-title":"Meta-analysis of the placebo response in antidepressant trials","volume":"118","author":"Rief","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.jad.2020.07.102_bib0025","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.102_bib0026","series-title":"Statistical Pitfalls of Personalized Medicine","author":"Senn","year":"2018"},{"key":"10.1016\/j.jad.2020.07.102_bib0027","unstructured":"Team, R.C., 2013. R: a language and environment for statistical computing."},{"key":"10.1016\/j.jad.2020.07.102_bib0028","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"Turner","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jad.2020.07.102_bib0029","doi-asserted-by":"crossref","first-page":"115","DOI":"10.9758\/cpn.2016.14.2.115","article-title":"Neuroscience-based Nomenclature (NbN) for Clinical Psychopharmacology and Neuroscience","volume":"14","author":"Uchida","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jad.2020.07.102_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.jad.2020.07.102_bib0031","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S2215-0366(14)00092-3","article-title":"Placebo effects in psychiatry: mediators and moderators","volume":"2","author":"Weimer","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2020.07.102_bib0032","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S2215-0366(14)00092-3","article-title":"Placebo effects in psychiatry: mediators and moderators","volume":"2","author":"Weimer Katjia","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2020.07.102_bib0033","series-title":"Depression and Other Common Mental Disorders: Global Health Estimates","year":"2017"},{"key":"10.1016\/j.jad.2020.07.102_bib0034","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the Hamilton Depression Rating Scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720325477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720325477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:57:39Z","timestamp":1759024659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032720325477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":36,"alternative-id":["S0165032720325477"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.07.102","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The magnitude and heterogeneity of antidepressant response in depression: A meta-analysis of over 45,000 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.07.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}